论文部分内容阅读
目的分析194例乳腺癌综合治疗的疗效,探讨乳腺癌治疗后影响其生存、复发、转移及预后的因素。方法对1998年6月至2008年6月在本院治疗满5年全部乳腺癌患者进行回顾性随访,将临床资料结果进行总结分析。结果本组乳腺癌5年生存率为53.09%,生存率较低与延误诊治时机、肿块分期、病理类型、腋淋巴结转移、胸肌转移、激素受体以及综合治疗情况等诸多因素有关。结论乳腺癌5年生存率虽然仅为53.09%,但如果能早期发现,早期诊断,早期进行以手术、化疗及内分泌治疗为主的综合治疗,乳腺癌生存率还可提高。
Objective To analyze the curative effect of 194 cases of breast cancer comprehensive treatment and to explore the factors that influence the survival, recurrence, metastasis and prognosis of breast cancer after treatment. Methods A retrospective study was performed on all patients with breast cancer who were treated in our hospital from June 1998 to June 2008 for 5 years. The clinical data were summarized and analyzed. Results The 5-year survival rate of breast cancer patients was 53.09%. The low survival rate was related to the timing of delayed diagnosis and treatment, tumor stage, pathological type, axillary lymph node metastasis, chest muscle metastasis, hormone receptor and comprehensive treatment. Conclusions Although the 5-year survival rate of breast cancer is only 53.09%, the survival rate of breast cancer can be improved if it can be detected early, early diagnosed and treated early comprehensively by surgery, chemotherapy and endocrine therapy.